Inferring the effective TOR-dependent network: a computational study in yeast
© Mohammadi et al.; licensee BioMed Central Ltd. 2013
Received: 23 April 2013
Accepted: 28 August 2013
Published: 30 August 2013
Calorie restriction (CR) is one of the most conserved non-genetic interventions that extends healthspan in evolutionarily distant species, ranging from yeast to mammals. The target of rapamycin (TOR) has been shown to play a key role in mediating healthspan extension in response to CR by integrating different signals that monitor nutrient-availability and orchestrating various components of cellular machinery in response. Both genetic and pharmacological interventions that inhibit the TOR pathway exhibit a similar phenotype, which is not further amplified by CR.
In this paper, we present the first comprehensive, computationally derived map of TOR downstream effectors, with the objective of discovering key lifespan mediators, their crosstalk, and high-level organization. We adopt a systematic approach for tracing information flow from the TOR complex and use it to identify relevant signaling elements. By constructing a high-level functional map of TOR downstream effectors, we show that our approach is not only capable of recapturing previously known pathways, but also suggests potential targets for future studies.
Information flow scores provide an aggregate ranking of relevance of proteins with respect to the TOR signaling pathway. These rankings must be normalized for degree bias, appropriately interpreted, and mapped to associated roles in pathways. We propose a novel statistical framework for integrating information flow scores, the set of differentially expressed genes in response to rapamycin treatment, and the transcriptional regulatory network. We use this framework to identify the most relevant transcription factors in mediating the observed transcriptional response, and to construct the effective response network of the TOR pathway. This network is hypothesized to mediate life-span extension in response to TOR inhibition.
Our approach, unlike experimental methods, is not limited to specific aspects of cellular response. Rather, it predicts transcriptional changes and post-translational modifications in response to TOR inhibition. The constructed effective response network greatly enhances understanding of the mechanisms underlying the aging process and helps in identifying new targets for further investigation of anti-aging regimes. It also allows us to identify potential network biomarkers for diagnosis and prognosis of age-related pathologies.
KeywordsTarget of rapamycin (TOR) Yeast aging Interactome Information flow analysis Effective response network
Cellular aging is a multi-factorial complex phenotype, characterized by the accumulation of damaged cellular components over the organism’s life-span . The progression of aging depends on both the increasing rate of damage to DNA, RNA, proteins, and cellular organelles, as well as the gradual decline of cellular defense mechanisms against stress. This can ultimately lead to a dysfunctional cell with a higher risk factor for disease.
Limiting caloric intake without causing malnutrition, also known as calorie restriction (CR), is one of the most conserved non-genetic interventions, which extends life-span in evolutionarily distant species ranging from yeast to mammals [1–3]. Inhibition of the nutrient-sensing pathways, using either genetic or pharmacological intervention, also results in a similar phenotype [1, 2]. More importantly, increased lifespan is accompanied by an increased healthspan, which delays both the progression and the increasing risk-factor for a wide range of age-related diseases, including cancers [4–7], cardiovascular disease [8–11], and multiple neurodegenerative disorders [12–17]. The extent to which these pathologies share their underlying biology is a topic of active investigation. Emerging evidence, however, supports the hypothesis that large classes of age-related diseases are driven by similar underlying mechanisms . Understanding and controlling these mechanisms, therefore, constitute critical aspects of preventing or delaying the onset of age-related pathologies. Motivated by these observations, considerable effort has been invested in understanding the downstream effectors of the nutrient-sensing pathways that orchestrate CR-mediated life-span extension.
The budding yeast, Saccharomyces cerevisiae, has been used extensively as a model organism in aging research, due to its rapid growth and ease of manipulation [3, 19]. Having two different aging paradigms – replicative life-span (RLS), defined as “the number of buds a mother cell can produce before senescence occurs”, and chronological life-span (CLS), defined as “the duration of viability after entering the stationary-phase”, yeast provides a unique opportunity for modeling both proliferating and post-mitotic cells. Understanding the underlying mechanisms driving RLS and CLS can ultimately be used to shed light on the progression of cancers and neurodegenerative diseases, respectively.
Yeast cells are typically cultured in growth media containing 2% glucose. Reducing glucose concentration to 0.5% or less is one of the best characterized CR regimens in yeast, which increases both CLS and RLS [20–22]. The target of rapamycin (TOR) has been shown to play a key role in mediating the observed life-span extension in response to CR . TOR is a serine/threonine protein kinase, which belongs to the conserved family of PI3K-related kinases (PIKKs). It was first identified using genetic studies in yeast while searching for mutants that confer rapamycin-resistance . It was later discovered that TOR protein kinases, encoded by TOR1 and TOR2 genes in yeast, form two structurally and functionally distinct multiprotein complexes [25–28]. TOR Complex 1 (TORC1) is rapamycin-sensitive and consists of both TOR proteins, TOR1 and TOR2, together with KOG1, LST8, and TCO89. On the other hand, TOR Complex 2 (TORC2) does not contain TOR1, is not inhibited by rapamycin, and contains AVO1, AVO2, AVO3, LST8, BIT2, and BIT61. These two complexes correspond to two separate branches of the TOR signaling network, controlling the spatial and temporal aspects of cell growth, respectively, which are conserved from yeast to humans . Interestingly, TORC1 also has a critical role in aging and age-related pathologies [29, 30]. Many of the known oncoproteins act as upstream activators of TORC1, while several tumor suppressor proteins inhibit its activity [31, 32]. From a systems point of view, TORC1 acts as a hub that integrates various nutrient and stress-related signals and regulates a variety of cellular responses [33–35]. Inhibiting TOR signaling using rapamycin provides a unique opportunity to identify its downstream effectors. However, these targets may be regulated in different ways, including, but not limited to, transcription regulation, translational control, and post-translational modifications. Capturing various changes that happen during rapamycin treatment, in order to create a comprehensive systems view of the cellular response, is a complex task.
In this paper, we propose a complementary, computational approach to reconstruct a comprehensive map of TOR downstream effectors. We develop a systematic approach to couple random walk techniques with rigorous statistical models, integrate different datasets, and identify key targets in calorie restriction that are mediated by TOR pathway. Using GO enrichment analysis of high scoring nodes, we show that information flow analysis not only identifies previously known targets of TORC1, but also predicts new functional roles for further studies. We cross-validate our results with transcriptome profile of yeast in response to rapamycin treatment and show that our method can accurately predict transcriptional changes in response to TORC1 inhibition. Information flow scores provide an aggregate ranking of proteins, with respect to their relevance to the TOR signaling pathway, and are highly susceptible to degree bias. To remedy this and to elucidate the roles of underlying signaling elements, we propose a novel statistical framework for integrating information flow scores, data on regulatory relationships, and the expression profile in response to rapamycin treatment.
Using our framework, we identify the most relevant transcription factors and construct the effective response network of TOR, which is responsible for the observed transcriptional changes due to TOR inhibition. Our approach, unlike experimental methods, is not limited to specific aspects of cellular response. Rather, it predicts transcriptional changes, as well as post-translational modifications in response to TOR signaling. The resulting interaction map greatly enhances our understanding of the mechanisms underlying the aging process and helps identify novel targets for further investigation of anti-aging regimes. It also reveals potential network biomarkers for diagnoses and prognoses of age-related pathologies and identifies mechanisms for control of cellular aging processes through multi-targeted and combinatorial therapies [36, 37].
Results and discussion
Computing information flow scores from TORC1
Node rankings from the random walk process are susceptible to degree-bias, favoring high-degree nodes. To remedy this bias and to gain a detailed mechanistic understanding of the roles of various proteins (and associated signaling elements), random walk methods need to be coupled with appropriate statistical tests. A key contribution of our work is the development of such a test, which yields a fine-grained understanding of key pathways involved in orchestrating cellular response to TOR inhibition. To the best of our knowledge, this work represents the first application of information flow methods for reconstructing the effective response network of TORC1.
Constructing a high-level functional map of TOR downstream effectors
TORC1 is not only regulated by the quality and the quantity of both carbon and nitrogen sources [34, 38–40], but also by noxious stressors, such as caffeine [41, 42]. In response, TORC1 coordinately orchestrates various aspects of cellular machinery to mediate cell growth [32, 40]. This includes autophagy , stress response [42, 44], and protein synthesis (by regulating ribosome biogenesis , translation initiation , and nutrient uptake [47, 48]).
In order to systematically identify the functional aspects relevant to TOR signaling, we first rank the proteins in the yeast interactome based on their information flow scores from the TORC1 complex. Given this ranked list, we aim to identify functional terms that are highly over-represented among top-ranked proteins. Gene Ontology (GO)  enrichment analysis has been used extensively for this purpose. We employ GOrilla  to find the optimal cut for each GO term, together with its exact minimum hypergeometric (mHG) p-value. Next, we enforce a threshold of p-value≤10−3 to identify the significant terms. The complete list of enriched terms for each branch of GO is available for download as Additional files 2.
First, we note that most of the previously known targets of TORC1 are also identified by our information flow method, as represented in the enrichment map. For example, all terms related to ribosome biogenesis, including relevant cellular components (such as ribosome and nucleolus), molecular functions (such as rRNA binding and structural constitute of ribosome), and biological processes (such as rRNA processing and ribosomal subunit export from nucleus), are clustered in the bottom-left corner of the map. These terms, interestingly, are also clustered with other terms related to protein synthesis, such as regulation of translation, translational initiation, and cytoplasmic translation. Furthermore, many of the terms related to stress-response, such as response to DNA damage stimulus and DNA repair, are clustered in the bottom-left corner of the map. Finally, many of the terms related to TOR signaling, nutrient uptake, and cytoskeleton organization are grouped on the top section of the map.
Comparison of predicted targets to the set of differentially expressed genes in response to Rapamycin treatment
Rapamycin, a lipophilic macrolide originally purified as an antifungal agent and then re-discovered as an immunosuppressive drug, forms a toxic complex with its intracellular receptor FKBP12, encoded by the Fpr1 gene in yeast, and directly binds to TOR in order to perform its inhibitory action . We hypothesize that if the information flow-based method agrees with the TORC1 signaling network, it should be able to predict transcriptional changes due to rapamycin treatment, which inhibits TORC1 in vivo. To validate this hypothesis, we used a recent mRNA expression profile of yeast in response to rapamycin treatment . We extracted the set of differentially expressed genes, at a minimum threshold of 2-fold change, and constructed a vector of true positives from this set by filtering out genes that do not have a corresponding vertex in the yeast interactome. The final dataset includes 342 repressed and 237 induced genes in our experiment.
Post-translational modifications among top-ranked proteins: a case study on Gap1 regulation
An interesting observation from Figure 5 is that the highest-ranked genes (approximately the top 150 genes), marked with a red box, are not enriched in terms of rapamycin-induced genes. This can be explained by the fact that regulatory elements in the TOR signaling pathway, including TFs, do not typically change their expression level in response to TOR signaling. Instead, they are targeted for post-translational modifications (typically, phosphorylation). We consequently hypothesize that the top genes should also be enriched in terms of phosphorylation events. To further investigate this hypothesis, we focus on a case study of Gap1 regulation, a general amino acid permease regulated by NCR. We choose Gap1 since its regulatory pathway, originating from TORC1, is well-studied in literature. Moreover, data from phosphoproteomic experiments, which measures phosphorylation events among elements of this pathway, is readily available. Specifically, Gap1 is positively regulated via Gln3 and Gat1, while it is repressed by Gzf3 and Dal80 [34, 40]. Interestingly, all four of these regulators are among top-ranked transcription factors, yet none of them are differentially expressed in response to rapamycin treatment. Using a recent phosphoproteome of yeast in response to rapamycin treatment , we validated that both of the transcriptional activators of Gap1, namely Gln3 and Gat1, are highly phosphorylated in response to rapamycin treatment. Moreover, Tap42-Sit4, which is the upstream regulator of Gcn4, is indirectly regulated by TORC1.
Sensitivity and specificity of information flow scores in predicting key transcription factors
Top-ranked proteins in information flow analysis are highly enriched in terms of differentially expressed genes under rapamycin treatment. However, TORC1 does not directly regulate expression of these genes. This observation raises the question: which transcription factors are responsible and which intermediary elements are involved in these regulations? We answer the first question here, while deferring the latter to subsequent sections.
To find the key transcription factors that modulate the observed transcriptional response, we use two separate statistical predictors, one based on the information flow scores and the other based on the set of differentially expressed genes. These predictors allow us to assess the significance of TFs with respect to their computationally computed, top-ranked and experimentally validated targets, respectively. In the first method, we call a transcription factor relevant if a significant fraction of its target genes are highly-ranked in information flow method. Conversely, in the second method we define the relevance in terms of the portion of its differentially expressed targets (please see Equations 6-8 for details).
We use p-value(X=k T ) and p-value(Y=k P ) and apply a cutoff value of ε=0.01 to identify significant p-values computed for computational and experimental predictions, respectively. At this threshold, we compute the sensitivity and specificity of information flow methods as 0.2245 and 0.9846, respectively. The observed high specificity value suggests that if targets of a given TF are not differentially expressed, with high probability, our computational model also reports it as a negative (it will not have significant number of top-ranked targets). In other words, transcription factors that are identified as significant using information flow scores are highly precise. On the other hand, the lower sensitivity score implies that even if a TF has many differentially expressed targets, our computational method may miss it. From this, we can conclude that transcription factors that have significant numbers of top-ranked targets are high-confidence candidate(s) as downstream effectors of TORC1. However, there are cases where we may miss relevant transcription factors with a significant number of differentially expressed genes by this approach. In the next section, we propose a statistical framework to integrate information flow scores and expression profiles to reliably identify the most relevant subset of transcription factors that are involved in mediating the transcriptional response to TOR inhibition, and consequently construct the effective response network of TORC1.
Identifying the most relevant transcription factors
We now seek to integrate experimental measurements from rapamycin treatment, information flow scores, and the transcription regulatory network into a unified framework to identify the most relevant transcription factors. To this end, we introduce the notion of relevance score. Let random variable Z denote the number of top-ranked positive targets, and k T P denote the number of top-ranked positive targets of a given TF. We define the relevance score as − log(p-value(Z=k T P )). The relevance score assesses both positivity and rank of the targets for a given TF (please see Equation 10 for details). Using this approach, we identify 17 TFs with high relevance scores, which are hypothesized to be responsible for the transcriptional changes in a TORC1-dependent manner. The complete list of computed statistics for all transcription factors is summarized in Additional file 4.
Top-ranked transcription factors with high confidence scores
However, to the best of our knowledge, Ste12 and Yap1 have not been previously positioned downstream of TORC1. Ste12 is best known as a downstream target of mitogen-activated protein kinase (MAPK) signaling cascade and is responsible for regulating genes involved in mating or pseudohyphal/invasive growth . Rutherford et al.  show that over-expression of the ammonium permease Mep2 induces the transcription of known targets of Ste12. A more recent study by Santos et al.  additionally positions TORC1 downstream of Mep2, which, taken together with the link between Mep2-Ste12, suggests Ste12 as a potential downstream effector of TORC1. Yap1 is an AP-1 family transcription factor required for inducing oxidative [70, 71] and carbon  stress responses, the latter is proposed to be independent of TORC1. Additionally, Yap1 expression has been shown to increase significantly during replicative aging . It has been suggested that spermidine, a conserved longevity factor , mediates macroautophagy in a Yap1 and Gcn4 dependent manner . Finally, there is a diverse set of age-related functions associated with Yap1, many of which are also attributed to TORC1. These observations suggest Yap1 as a potential candidate downstream effector of TORC1.
Constructing the effective response network of TORC1
Understanding various processes associated with aging has important implications for the diagnosis, prognosis, and treatment of age-related pathologies. Current methods for constructing aging pathways rely on detailed experiments that study cellular response to carefully controlled signals. This process is expensive, time-consuming, and typically restricted to specific aspects of cellular response. In this study, we presented a complementary, computational approach that aims to construct detailed aging pathways using the yeast interactome by initiating random walks at proteins that are key players in the aging process (the target of rapamycin or TOR, in this study). At the heart of our method is a rigorous statistical and computational framework that identifies significant effector proteins and provides information about the specific mechanisms associated with them.
We present comprehensive validation of our computational results through GO enrichment studies and manual curation to show that our method identifies most of the known proteins downstream from TOR, while identifying several new proteins for future experimental investigations. Additionally, we showed that information flow scores faithfully predict transcriptional changes in response to rapamycin-treatment, which validates accuracy of predicted effectors. Furthermore, we show that the predicted targets are also enriched with proteins that are post-translationally modified (i.e., phosphorylated) in response to TOR inhibition. Finally, we constructed the effective response network of the TOR pathway. This network is hypothesized to mediate transcriptional changes in response to TOR inhibition. A direct outcome of our study is a complete dataset of proteins downstream of TOR, their interactions, functional roles, and organization.
Constructing yeast interactome
We obtained the yeast protein-protein interactions (PPI) from the BioGRID  database, update 2011 , version 3.1.83, by extracting all physical interactions, except for protein-RNA interactions, and excluding interspecies and self interactions. This dataset consists of 103,619 (63,395 non-redundant) physical interactions among 5,691 proteins, and is available for download as Additional file 8. We then identified the subset of interactions associated with post-translational modification (PTM), marked with the “biochemical activity” evidence code in BioGRID, resulting in 5,791 (5,443 non-redundant) biochemical activities among proteins in yeast. These are available for download as Additional file 9. Each of these interactions represents a directional enzymatic activity, where the bait protein executes the activity on the substrate hit protein. After integrating different modifications among similar pairs of proteins, we obtained 5,421 directional edges among 2,002 proteins in the yeast interactome. The bulk of these interactions (over 4,000) are the phosphorylation events identified by Ptacek et al.  using proteome chip technology.
We constructed the integrated network of yeast interactions, the yeast interactome, by integrating protein-protein interactions(PPIs) and post-translational modifications(PTMs). For pairs of proteins that have both PPI and PTM, we give higher priority to PTM, since it provides a more refined description of the type of interaction. Figure 1 illustrates an example of the integration process around the Sch9 protein, which is a well-documented substrate of TORC1. The final constructed interactome is available for download as Additional file 10. This network consists of 5,287 uni-directional and 58,108 bi-directional edges (58,041 PPIs and 134 bi-directional PTMs) among 5,691 nodes. The node attributes and alternative labels for each node in the yeast interactome are also available for download as Additional file 11.
Transcriptional regulatory network (TRN) of yeast
We constructed the yeast transcriptional regulatory network (TRN) from the documented regulations in YEASTRACT , consisting of 48,082 interactions between 183 transcription factors (TF) and 6,403 target genes (TG). Among these 183 TFs, 179 of them have a corresponding node in the yeast interactome.
Tracing information flow in the interactome
We use a computational approach, based on a discrete-time random walk process, to track directional information flow in the interactome. Similar formulations have been previously used to prioritize candidate disease genes [82, 83], discover network bio-markers for cancer , and identify protein complexes [85, 86]. Additionally, there is a known correspondence between random-walk methods on undirected graphs and formulations based on circuit network models . Our formulation takes into account both network distances, as well as multiplicity of paths between pairs of proteins. It also benefits from using edge directions (when available) to discriminate between upstream regulators and downstream effectors.
Let G=(V,E) be a mixed graph, having both directed and undirected edges. Each node in V corresponds to a protein and edge (u,v)∈E iff protein u interacts with protein v in the integrated network. Graph G can be represented using its adjacency matrix A, where A i j =1, if node i has a directed edge to node j, and is 0 otherwise. Undirected edges are replaced by a pair of directed edges in each direction. A random walk on G, initiated from vertex v, is defined as a sequence of transitions among vertices, starting from v. At each step, the random walker randomly chooses the next vertex from among the neighbors of the current node. The sequence of visited vertices generated by this random process is a Markov chain, since the choice of next vertex depends only on the current node. We can represent the transition matrix of this Markov process as a column-stochastic matrix, P, where p i j =P r(St+1=v i |S t =v j ), and random variable S t represents the state of the random walk at the time step t.
where the right-multiplication with e v simply selects column v of the matrix Q. The factor 1−α can be viewed as the decay factor of the signal; the higher the parameter α, the further the signal can propagate. Let us denote by random variable R the number of hops taken by random walker before it jumps back to source node v. Then, R follows a geometric distribution with probability of success (1−α) and the expected (mean) length of paths taken by random walker can be computed as . In other words, if we let , for a given value of d, we expect the average length of paths taken by such a random walk to be equivalent to d, thus we call d the depth of the random walk.
Cross-validating information flow scores with the set of differentially expressed genes in response to TOR inhibition
Given the list of gene products ranked by their information flow scores, we want to assess the enrichment of differentially expressed genes, in response to rapamycin treatment, among top-ranked proteins.
Next, we use a dynamic programming (DP) method to compute the exact p-value of the observed mHG score, in the state space of all possible λ vectors with size N having exactly A ones (please refer to Eden et al.  for algorithmic details, and Eden  for an efficient implementation). We adopt this strategy to cross-validate our results with the transcriptome profile of yeast cells in response to rapamycin treatment. We subsequently define the enrichment plot, which illustrates the absolute value of the logarithm of the HG score as a function of cutoff percentage. The minimum hypergeometric (mHG) score can be viewed as the peak of this plot, and the corresponding exact p-value can be computed for this peak using the aforementioned DP algorithm.
Assessing the sensitivity and the specificity of information flow scores
Given an optimal cutoff length l (computed for differentially expressed genes in response to TOR inhibition), which partitions nodes into top/bottom ranked proteins, together with a transcription factor (TF) of interest, p i , we are interested in assessing the importance of p i in mediating the observed transcriptional response. In other words, given that p i has a significant number of top-ranked targets, how confident are we that it will also have a significant number of differentially expressed targets? Conversely, if p i has many differentially expressed targets, how likely is it to see its targets among top-ranked genes?
Integrating computational predictions with experimental datasets
Given the set of differentially expressed genes in response to rapamycin treatment, the computed information flow scores, and the transcriptional regulatory network (TRN) of yeast, we aim to construct an integrative statistical framework to identify the most relevant transcription factors with respect to mediating the transcriptional response to TOR inhibition, and decipher the underlying effective response network.
After correcting for multiple hypothesis testing using Bonferroni method, we define the relevance score of each TF as − log10(p-value(Z = k T P )), and construct the effective response network of TORC1 using the most relevant TFs, together with their top-ranked positive targets, correspondingly.
Availability of supporting data
The data sets supporting the results of this article are included within the article (and its additional files). They are also available for download from http://compbio.soihub.org/projects/torc1. All necessary codes and datasets to reproduce the results in this paper are bundled as Additional file 12.
Target of rapamycin
This work is supported by the Center for Science of Information (CSoI), an NSF Science and Technology Center, under grant agreement CCF-0939370, and by NSF grants DBI 0835677 and 0800568.
- Fontana L, Partridge L, Longo VD: Extending healthy life span–from yeast to humans. Science (New York, N.Y.). 2010, 328 (5976): 321-326. 10.1126/science.1172539.View ArticleGoogle Scholar
- Bishop NA, Guarente L: Genetic links between diet and lifespan: shared mechanisms from yeast to humans. Nat Rev Genet. 2007, 8 (11): 835-844. 10.1038/nrg2188.PubMedView ArticleGoogle Scholar
- Kaeberlein M: Lessons on longevity from budding yeast. Nature. 2010, 464 (7288): 513-519. 10.1038/nature08981.PubMedPubMed CentralView ArticleGoogle Scholar
- Campisi J: Aging, cellular senescence, and cancer. Annu Rev Physiol. 2013, 75: 685-705. 10.1146/annurev-physiol-030212-183653.PubMedPubMed CentralView ArticleGoogle Scholar
- Provinciali M, Cardelli M, Marchegiani F, Pierpaoli E: Impact of cellular senescence in aging and cancer. Curr Pharm Des. 2013, 19 (9): 1699-709.PubMedGoogle Scholar
- Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, Allison DB, Cruzen C, Simmons HA, Kemnitz JW, Weindruch R: Caloric restriction delays disease onset and mortality in rhesus monkeys. Science (New York, N.Y.). 2009, 325 (5937): 201-204. 10.1126/science.1173635.View ArticleGoogle Scholar
- Finkel T, Serrano M, Blasco MA: The common biology of cancer and ageing. Nature. 2007, 448 (7155): 767-774. 10.1038/nature05985.PubMedView ArticleGoogle Scholar
- North BJ, Sinclair DA: The intersection between aging and cardiovascular disease. Circ Res. 2012, 110 (8): 1097-108. 10.1161/CIRCRESAHA.111.246876.PubMedPubMed CentralView ArticleGoogle Scholar
- Leritz EC, McGlinchey RE, Kellison I, Rudolph JL, Milberg WP: Cardiovascular disease risk factors and cognition in the elderly. Curr Cardiovasc Risk Rep. 2011, 5 (5): 407-412. 10.1007/s12170-011-0189-x.PubMedPubMed CentralView ArticleGoogle Scholar
- Cruzen C, Colman RJ: Effects of caloric restriction on cardiovascular aging in non-human primates and humans. Clin Geriatr Med. 2009, 25 (4): 733-43,. 10.1016/j.cger.2009.07.001. ix–xPubMedPubMed CentralView ArticleGoogle Scholar
- Mattson MP, Wan R: Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J Nutr Biochem. 2005, 16 (3): 129-137. 10.1016/j.jnutbio.2004.12.007.PubMedView ArticleGoogle Scholar
- Collier TJ, Kanaan NM, Kordower JH: Ageing as a primary risk factor for Parkinson’s disease: evidence from studies of non-human primates. Nat Rev Neurosci. 2011, 12 (6): 359-366. 10.1038/nrn3039.PubMedPubMed CentralView ArticleGoogle Scholar
- Dartigues JF, Féart C: Risk factors for Alzheimer disease: aging beyond age?. Neurology. 2011, 77 (3): 206-207. 10.1212/WNL.0b013e31822550af.PubMedView ArticleGoogle Scholar
- Duan W, Ross CA: Potential therapeutic targets for neurodegenerative diseases: lessons learned from calorie restriction. Curr Drug Targets. 2010, 11 (10): 1281-1292. 10.2174/1389450111007011281.PubMedView ArticleGoogle Scholar
- Noorbakhsh F, Overall CM, Power C: Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology. Trends Neurosci. 2009, 32 (2): 88-100. 10.1016/j.tins.2008.10.003.PubMedView ArticleGoogle Scholar
- Maswood N, Young J, Tilmont E, Zhang Z, Gash DM, Gerhardt GA, Grondin R, Roth GS, Mattison J, Lane MA, Carson RE, Cohen RM, Mouton PR, Quigley C, Mattson MP, Ingram DK: Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson’s disease. Proc Natl Acad Sci USA. 2004, 101 (52): 18171-18176. 10.1073/pnas.0405831102.PubMedPubMed CentralView ArticleGoogle Scholar
- Wu P, Shen Q, Dong S, Xu Z, Tsien JZ, Hu Y: Calorie restriction ameliorates neurodegenerative phenotypes in forebrain-specific presenilin-1 and presenilin-2 double knockout mice. Neurobiol Aging. 2008, 29 (10): 1502-1511. 10.1016/j.neurobiolaging.2007.03.028.PubMedView ArticleGoogle Scholar
- Campisi J, Andersen JK, Kapahi P, Melov S: Cellular senescence: a link between cancer and age-related degenerative disease?. Semin Cancer Biol. 2011, 21 (6): 354-359.PubMedPubMed CentralGoogle Scholar
- Kaeberlein M, Burtner CR, Kennedy BK: Recent developments in yeast aging. PLoS Genet. 2007, 3 (5): e84-10.1371/journal.pgen.0030084.PubMedPubMed CentralView ArticleGoogle Scholar
- Lin SJ, Defossez PA, Guarente L: Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science (New York, N.Y.). 2000, 289 (5487): 2126-2128. 10.1126/science.289.5487.2126.View ArticleGoogle Scholar
- Kaeberlein M, Kirkland KT, Fields S, Kennedy BK: Sir2-independent life span extension by calorie restriction in yeast. PLoS Biol. 2004, 2 (9): E296-10.1371/journal.pbio.0020296.PubMedPubMed CentralView ArticleGoogle Scholar
- Smith DL, McClure JM, Matecic M, Smith JS: Calorie restriction extends the chronological lifespan of Saccharomyces cerevisiae independently of the Sirtuins. Aging cell. 2007, 6 (5): 649-662. 10.1111/j.1474-9726.2007.00326.x.PubMedView ArticleGoogle Scholar
- Kaeberlein M, Powers RW, Steffen KK, Westman EA, Hu D, Dang N, Kerr EO, Kirkland KT, Fields S, Kennedy BK: Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science (New York, N.Y.). 2005, 310 (5751): 1193-1196. 10.1126/science.1115535.View ArticleGoogle Scholar
- Heitman J, Movva NR, Hall MN: Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science (New York, N.Y.). 1991, 253 (5022): 905-909. 10.1126/science.1715094.View ArticleGoogle Scholar
- Loewith R, Jacinto E, Wullschleger S, Lorberg A, Crespo JL, Bonenfant D, Oppliger W, Jenoe P, Hall MN: Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell. 2002, 10 (3): 457-468. 10.1016/S1097-2765(02)00636-6.PubMedView ArticleGoogle Scholar
- Wedaman KP, Reinke A, Anderson S, Yates J, McCaffery JM, Powers T: Tor kinases are in distinct membrane-associated protein complexes in Saccharomyces cerevisiae. Mol Biol Cell. 2003, 14 (3): 1204-1220. 10.1091/mbc.E02-09-0609.PubMedPubMed CentralView ArticleGoogle Scholar
- Reinke A, Anderson S, McCaffery JM, Yates J, Aronova S, Chu S, Fairclough S, Iverson C, Wedaman KP, Powers T: TOR complex 1 includes a novel component, Tco89p (YPL180w), and cooperates with Ssd1p to maintain cellular integrity in Saccharomyces cerevisiae. J Biol Chem. 2004, 279 (15): 14752-14762. 10.1074/jbc.M313062200.PubMedView ArticleGoogle Scholar
- Wullschleger S, Loewith R, Hall MN: TOR signaling in growth and metabolism. Cell. 2006, 124 (3): 471-484. 10.1016/j.cell.2006.01.016.PubMedView ArticleGoogle Scholar
- Kapahi P, Chen D, Rogers AN, Katewa SD, Li PWL, Thomas EL, Kockel L: With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab. 2010, 11 (6): 453-465. 10.1016/j.cmet.2010.05.001.PubMedPubMed CentralView ArticleGoogle Scholar
- McCormick MA, Tsai SY, Kennedy BK: TOR and ageing: a complex pathway for a complex process. Philos Trans R Soc Lond B Biol Sci. 2011, 366 (1561): 17-27. 10.1098/rstb.2010.0198.PubMedPubMed CentralView ArticleGoogle Scholar
- De Virgilio C, Loewith R: Cell growth control: little eukaryotes make big contributions. Oncogene. 2006, 25 (48): 6392-6415. 10.1038/sj.onc.1209884.PubMedView ArticleGoogle Scholar
- Loewith R, Hall MN: Target of rapamycin (TOR) in nutrient signaling and growth control. Genetics. 2011, 189 (4): 1177-1201. 10.1534/genetics.111.133363.PubMedPubMed CentralView ArticleGoogle Scholar
- De Virgilio C, Loewith R: The TOR signalling network from yeast to man. Int J Biochem Cell Biol. 2006, 38 (9): 1476-1481. 10.1016/j.biocel.2006.02.013.PubMedView ArticleGoogle Scholar
- Zaman S, Lippman SI, Zhao X, Broach JR: How Saccharomyces responds to nutrients. Annu Rev Genet. 2008, 42: 27-81. 10.1146/annurev.genet.41.110306.130206.PubMedView ArticleGoogle Scholar
- Wei Y, Zheng XFS: Nutritional control of cell growth via TOR signaling in budding yeast. Methods Mol Biol (Clifton, N.J.). 2011, 759: 307-319. 10.1007/978-1-61779-173-4_18.View ArticleGoogle Scholar
- Le Couteur DG, McLachlan AJ, Quinn RJ, Simpson SJ, de Cabo R: Aging biology and novel targets for drug discovery. J Gerontol A Biol Sci Med Sci. 2012, 67 (2): 168-174.PubMedView ArticleGoogle Scholar
- Naylor RM, Baker DJ, van Deursen JM: Senescent cells: a novel therapeutic target for aging and age-related diseases. Clin Pharmacol Ther. 2013, 93: 105-116. 10.1038/clpt.2012.193.PubMedPubMed CentralView ArticleGoogle Scholar
- Binda M, Péli-Gulli MP, Bonfils G, Panchaud N, Urban J, Sturgill TW, Loewith R, De Virgilio C: The Vam6 GEF controls TORC1 by activating the EGO complex. Mol Cell. 2009, 35 (5): 563-573. 10.1016/j.molcel.2009.06.033.PubMedView ArticleGoogle Scholar
- Neklesa TK, Davis RW: A genome-wide screen for regulators of TORC1 in response to amino acid starvation reveals a conserved Npr2/3 complex. PLoS Genet. 2009, 5 (6): e1000515-10.1371/journal.pgen.1000515.PubMedPubMed CentralView ArticleGoogle Scholar
- Smets B, Ghillebert R, De Snijder P, Binda M, Swinnen E, De Virgilio C, Winderickx J: Life in the midst of scarcity: adaptations to nutrient availability in Saccharomyces cerevisiae. Curr Genet. 2010, 56: 1-32. 10.1007/s00294-009-0287-1.PubMedView ArticleGoogle Scholar
- Kuranda K, Leberre V, Sokol S, Palamarczyk G, François J: Investigating the caffeine effects in the yeast Saccharomyces cerevisiae brings new insights into the connection between TOR, PKC and Ras/cAMP signalling pathways. Mol Microbiol. 2006, 61 (5): 1147-1166. 10.1111/j.1365-2958.2006.05300.x.PubMedView ArticleGoogle Scholar
- Wanke V, Cameroni E, Uotila A, Piccolis M, Urban J, Loewith R, De Virgilio C: Caffeine extends yeast lifespan by targeting TORC1. Mol Microbiol. 2008, 69: 277-285. 10.1111/j.1365-2958.2008.06292.x.PubMedView ArticleGoogle Scholar
- Chang YY, Juhász G, Goraksha-Hicks P, Arsham AM, Mallin DR, Muller LK, Neufeld TP: Nutrient-dependent regulation of autophagy through the target of rapamycin pathway. Biochem Soc Trans. 2009, 37 (Pt 1): 232-236.PubMedView ArticleGoogle Scholar
- Gasch AP, Werner-Washburne M: The genomics of yeast responses to environmental stress and starvation. Funct Integr Genomics. 2002, 2 (4–5): 181-192.PubMedView ArticleGoogle Scholar
- Jorgensen P, Rupes I, Sharom JR, Schneper L, Broach JR, Tyers M: A dynamic transcriptional network communicates growth potential to ribosome synthesis and critical cell size. Genes Dev. 2004, 18 (20): 2491-2505. 10.1101/gad.1228804.PubMedPubMed CentralView ArticleGoogle Scholar
- Barbet NC, Schneider U, Helliwell SB, Stansfield I, Tuite MF, Hall MN: TOR controls translation initiation and early G1 progression in yeast. Mol Biol Cell. 1996, 7: 25-42. 10.1091/mbc.7.1.25.PubMedPubMed CentralView ArticleGoogle Scholar
- Schmidt A, Beck T, Koller A, Kunz J, Hall MN: The TOR nutrient signalling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permease. EMBO J. 1998, 17 (23): 6924-6931. 10.1093/emboj/17.23.6924.PubMedPubMed CentralView ArticleGoogle Scholar
- Beck T, Hall MN: The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors. Nature. 1999, 402 (6762): 689-692. 10.1038/45287.PubMedView ArticleGoogle Scholar
- Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000, 25: 25-29. 10.1038/75556.PubMedPubMed CentralView ArticleGoogle Scholar
- Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z: GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics. 2009, 10: 48-10.1186/1471-2105-10-48.PubMedPubMed CentralView ArticleGoogle Scholar
- Cherry JM, Hong EL, Amundsen C, Balakrishnan R, Binkley G, Chan ET, Christie KR, Costanzo MC, Dwight SS, Engel SR, Fisk DG, Hirschman JE, Hitz BC, Karra K, Krieger CJ, Miyasato SR, Nash RS, Park J, Skrzypek MS, Simison M, Weng S, Wong ED: Saccharomyces Genome Database: the genomics resource of budding yeast. Nucleic Acids Res. 2012, 40 (Database issue): D700-D705.PubMedPubMed CentralView ArticleGoogle Scholar
- Merico D, Isserlin R, Stueker O, Emili A, Bader GD: Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PloS one. 2010, 5 (11): e13984-10.1371/journal.pone.0013984.PubMedPubMed CentralView ArticleGoogle Scholar
- Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T: Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics (Oxford, England). 2011, 27 (3): 431-432. 10.1093/bioinformatics/btq675.View ArticleGoogle Scholar
- Hampsey M: Molecular genetics of the RNA polymerase II general transcriptional machinery. Microbiol Mol Biol Rev. 1998, 62 (2): 465-503.PubMedPubMed CentralGoogle Scholar
- Maston GA, Evans SK, Green MR: Transcriptional regulatory elements in the human genome. Annu Rev Genomics Hum Genet. 2006, 7: 29-59. 10.1146/annurev.genom.7.080505.115623.PubMedView ArticleGoogle Scholar
- Fournier ML, Paulson A, Pavelka N, Mosley AL, Gaudenz K, Bradford WD, Glynn E, Li H, Sardiu ME, Fleharty B, Seidel C, Florens L, Washburn MP: Delayed correlation of mRNA and protein expression in rapamycin-treated cells and a role for Ggc1 in cellular sensitivity to rapamycin. Mol Cell Proteomics. 2010, 9 (2): 271-284. 10.1074/mcp.M900415-MCP200.PubMedPubMed CentralView ArticleGoogle Scholar
- Eden E, Lipson D, Yogev S, Yakhini Z: Discovering motifs in ranked lists of DNA sequences. PLoS Comput Biol. 2007, 3 (3): e39-10.1371/journal.pcbi.0030039.PubMedPubMed CentralView ArticleGoogle Scholar
- Huber A, Bodenmiller B, Uotila A, Stahl M, Wanka S, Gerrits B, Aebersold R, Loewith R: Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis. Genes Dev. 2009, 23 (16): 1929-1943. 10.1101/gad.532109.PubMedPubMed CentralView ArticleGoogle Scholar
- Lempiäinen H, Uotila A, Urban J, Dohnal I, Ammerer G, Loewith R, Shore D: Sfp1 interaction with TORC1 and Mrs6 reveals feedback regulation on TOR signaling. Mol cell. 2009, 33 (6): 704-716. 10.1016/j.molcel.2009.01.034.PubMedView ArticleGoogle Scholar
- Bertram PG, Choi JH, Carvalho J, Ai W, Zeng C, Chan TF, Zheng XF: Tripartite regulation of Gln3p by TOR, Ure2p, and phosphatases. J Biol Chem. 2000, 275 (46): 35727-35733. 10.1074/jbc.M004235200.PubMedView ArticleGoogle Scholar
- Steffen KK, MacKay VL, Kerr EO, Tsuchiya M, Hu D, Fox LA, Dang N, Johnston ED, Oakes JA, Tchao BN, Pak DN, Fields S, Kennedy BK, Kaeberlein M: Yeast life span extension by depletion of 60s ribosomal subunits is mediated by Gcn4. Cell. 2008, 133 (2): 292-302. 10.1016/j.cell.2008.02.037.PubMedPubMed CentralView ArticleGoogle Scholar
- Jorgensen P, Nishikawa JL, Breitkreutz BJ, Tyers M: Systematic identification of pathways that couple cell growth and division in yeast. Science (New York, N.Y.). 2002, 297 (5580): 395-400. 10.1126/science.1070850.View ArticleGoogle Scholar
- Marion RM, Regev A, Segal E, Barash Y, Koller D, Friedman N, O’Shea EK: Sfp1 is a stress- and nutrient-sensitive regulator of ribosomal protein gene expression. Proc Natl Acad Sci U S A. 2004, 101 (40): 14315-14322. 10.1073/pnas.0405353101.PubMedPubMed CentralView ArticleGoogle Scholar
- Courchesne WE, Magasanik B: Regulation of nitrogen assimilation in Saccharomyces cerevisiae: roles of the URE2 and GLN3 genes. J Bacteriol. 1988, 170 (2): 708-713.PubMedPubMed CentralGoogle Scholar
- Urban J, Soulard A, Huber A, Lippman S, Mukhopadhyay D, Deloche O, Wanke V, Anrather D, Ammerer G, Riezman H, Broach JR, De Virgilio C, Hall MN, Loewith R: Sch9 is a major target of TORC1 in Saccharomyces cerevisiae. Mol cell. 2007, 26 (5): 663-674. 10.1016/j.molcel.2007.04.020.PubMedView ArticleGoogle Scholar
- Hinnebusch AG: Translational regulation of GCN4 and the general amino acid control of yeast. Annu Rev Microbiol. 2005, 59: 407-450. 10.1146/annurev.micro.59.031805.133833.PubMedView ArticleGoogle Scholar
- Madhani HD, Fink GR: Combinatorial control required for the specificity of yeast MAPK signaling. Science (New York, N.Y.). 1997, 275 (5304): 1314-1317. 10.1126/science.275.5304.1314.View ArticleGoogle Scholar
- Rutherford JC, Chua G, Hughes T, Cardenas ME, Heitman J: A Mep2-dependent transcriptional profile links permease function to gene expression during pseudohyphal growth in Saccharomyces cerevisiae. Mol Biol Cell. 2008, 19 (7): 3028-3039. 10.1091/mbc.E08-01-0033.PubMedPubMed CentralView ArticleGoogle Scholar
- Santos J, MJa Sousa, Leão C: Ammonium is toxic for aging yeast cells, inducing death and shortening of the chronological lifespan. PloS one. 2012, 7 (5): e37090-10.1371/journal.pone.0037090.PubMedPubMed CentralView ArticleGoogle Scholar
- Stephen DW, Rivers SL, Jamieson DJ: The role of the YAP1 and YAP2 genes in the regulation of the adaptive oxidative stress responses of Saccharomyces cerevisiae. Mol Microbiol. 1995, 16 (3): 415-423. 10.1111/j.1365-2958.1995.tb02407.x.PubMedView ArticleGoogle Scholar
- Temple MD, Perrone GG, Dawes IW: Complex cellular responses to reactive oxygen species. Trends Cell Biol. 2005, 15 (6): 319-326. 10.1016/j.tcb.2005.04.003.PubMedView ArticleGoogle Scholar
- Wiatrowski HA, Carlson M: Yap1 accumulates in the nucleus in response to carbon stress in Saccharomyces cerevisiae. Eukaryot Cell. 2003, 2: 19-26. 10.1128/EC.2.1.19-26.2003.PubMedPubMed CentralView ArticleGoogle Scholar
- Yiu G, McCord A, Wise A, Jindal R, Hardee J, Kuo A, Shimogawa MY, Cahoon L, Wu M, Kloke J, Hardin J, Mays Hoopes LL: Pathways change in expression during replicative aging in Saccharomyces cerevisiae. J Gerontol A Biol Sci Med Sci. 2008, 63: 21-34. 10.1093/gerona/63.1.21.PubMedPubMed CentralView ArticleGoogle Scholar
- Eisenberg T, Knauer H, Schauer A, Büttner S, Ruckenstuhl C, Carmona-Gutierrez D, Ring J, Schroeder S, Magnes C, Antonacci L, Fussi H, Deszcz L, Hartl R, Schraml E, Criollo A, Megalou E, Weiskopf D, Laun P, Heeren G, Breitenbach M, Grubeck-Loebenstein B, Herker E, Fahrenkrog B, Fröhlich KU, Sinner F, Tavernarakis N, Minois N, Kroemer G, Madeo F: Induction of autophagy by spermidine promotes longevity. Nat Cell Biol. 2009, 11 (11): 1305-1314. 10.1038/ncb1975.PubMedView ArticleGoogle Scholar
- Teixeira MC, Cabrito TR, Hanif ZM, Vargas RC, Tenreiro S, Sá-Correia I: Yeast response and tolerance to polyamine toxicity involving the drug : H+ antiporter Qdr3 and the transcription factors Yap1 and Gcn4. Microbiology. 2011, 157 (Pt 4): 945-956.PubMedView ArticleGoogle Scholar
- D’Andrea D, Grassi L, Mazzapioda M, Tramontano A: FIDEA: a server for the functional interpretation of differential expression analysis. 2013,http://www.nar.oxfordjournals.org/cgi/doi/10.1093/nar/gkt516,Google Scholar
- Lempiäinen H, Shore D: Growth control and ribosome biogenesis. Curr Opin Cell Biol. 2009, 21 (6): 855-863. 10.1016/j.ceb.2009.09.002.http://www.ncbi.nlm.nih.gov/pubmed/19796927, 10.1016/j.ceb.2009.09.002PubMedView ArticleGoogle Scholar
- Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M: BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 2006, 34 (Database issue): D535-D539.PubMedPubMed CentralView ArticleGoogle Scholar
- Stark C, Breitkreutz BJ, Chatr-Aryamontri A, Boucher L, Oughtred R, Livstone MS, Nixon J, Van Auken K, Wang X, Shi X, Reguly T, Rust JM, Winter A, Dolinski K, Tyers M: The BioGRID interaction database: 2011 update. Nucleic Acids Res. 2011, 39 (Database issue): D698-D704.PubMedPubMed CentralView ArticleGoogle Scholar
- Ptacek J, Devgan G, Michaud G, Zhu H, Zhu X, Fasolo J, Guo H, Jona G, Breitkreutz A, Sopko R, McCartney RR, Schmidt MC, Rachidi N, Lee SJ, Mah AS, Meng L, Stark MJR, Stern DF, De Virgilio C, Tyers M, Andrews B, Gerstein M, Schweitzer B, Predki PF, Snyder M: Global analysis of protein phosphorylation in yeast. Nature. 2005, 438 (7068): 679-684. 10.1038/nature04187.PubMedView ArticleGoogle Scholar
- Abdulrehman D, Monteiro PT, Teixeira MC, Mira NP, Lourenço AB, dos Santos, Cabrito TR, Francisco AP, Madeira SC, Aires RS, Oliveira AL, Sá-Correia I, Freitas AT: YEASTRACT: providing a programmatic access to curated transcriptional regulatory associations in Saccharomyces cerevisiae through a web services interface. Nucleic Acids Res. 2011, 39 (Database issue): D136-D140.PubMedPubMed CentralView ArticleGoogle Scholar
- Köhler S, Bauer S, Horn D, Robinson PN: Walking the interactome for prioritization of candidate disease genes. Am J Hum Genet. 2008, 82 (4): 949-958. 10.1016/j.ajhg.2008.02.013.PubMedPubMed CentralView ArticleGoogle Scholar
- Navlakha S, Kingsford C: The power of protein interaction networks for associating genes with diseases. Bioinformatics. 2010, 26 (8): 1057-1063. 10.1093/bioinformatics/btq076.PubMedPubMed CentralView ArticleGoogle Scholar
- Nibbe RK, Koyutürk M, Chance MR: An integrative -omics approach to identify functional sub-networks in human colorectal cancer. PLoS Comput Biol. 2010, 6: e1000639-10.1371/journal.pcbi.1000639.PubMedPubMed CentralView ArticleGoogle Scholar
- Macropol K, Can T, Singh AK: RRW: repeated random walks on genome-scale protein networks for local cluster discovery. BMC Bioinformatics. 2009, 10: 283-10.1186/1471-2105-10-283.PubMedPubMed CentralView ArticleGoogle Scholar
- Maruyama O, Chihara A: NWE: Node-weighted expansion for protein complex prediction using random walk distances. Proteome Sci. 2011, 9 (Suppl 1): S14-10.1186/1477-5956-9-S1-S14.PubMedPubMed CentralView ArticleGoogle Scholar
- Doyle P, Snell L: Random walks and electric networks. Carus mathematical monographs. 1984, Washington: DC: Mathematical Association of AmericaGoogle Scholar
- Brin S, Page L: The anatomy of a large-scale hypertextual Web search engine. Comput Netw ISDN Syst. 1998, 30 (1–7): 107-117.View ArticleGoogle Scholar
- Page L, Brin S, Motwani R, Winograd T: The PageRank citation ranking: bringing order to the web. Technical Report 1999-66, Stanford InfoLab 1999
- Jeh G, Widom J: Scaling personalized web search. Technical Report 2002–12, Stanford InfoLab 2002
- Haveliwala TH: Proceedings of the 11th International Conference on World Wide Web, WWW ’02. 2002, 517-526.Google Scholar
- Eden E: Discovering motifs in ranked lists of DNA sequences. PhD thesis. Technion - Israel Institute of Technology 2007Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.